Delivery Order SPE2DB20D2104-SPE2DB25FMFRS

Award Date 1/8/25
Potential Completion Date 1/30/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and covers the supply of pharmaceutical products, specifically TASIGNA 200 MG CAPSULE 28S. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025, and it is not designated as a...
This federal contract award, with a ceiling value of $5,624.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,457.03, is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,638.02 Firm Fixed Price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The contract has an ultimate completion date of February 4, 2025 and was awarded on January 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $11,249.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG capsules, a specialty medication, with a completion date of November 26, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $5,624.62, is for the supply of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The contract has a period of performance through April 19, 2023 and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating it was competitively awarded....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.02, is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH8BQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,819.01 firm-fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,624.62 firm fixed price delivery order is for the drug TASIGNA 200 MG CAPSULE 28S. The contract has an ultimate completion date of April 27, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFRS
    Delivery Order

This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, with a performance period running through January 30, 2025.

The contract was issued as a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/9/25, 9:53 AM